FDAnews
www.fdanews.com/articles/165179-fda-warns-biologic-manufacturer-for-various-gmp-deficiencies

FDA Warns Biologic Manufacturer for Various GMP Deficiencies

June 13, 2014
The FDA has issued a warning letter to Mexican biologics maker Instituto Bioclon for significant GMP deviations including failures to ensure adequate environmental monitoring and employee training.
Drug GMP Report